Clinical Trial Update: Serum Potassium Prediction Using Machine Learning and Single-lead ECG

View source ↗

Summary

A Brigham and Women's Hospital clinical trial evaluating potassium prediction from machine learning and a single-lead ECG has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atrial Fibrillation
• Chronic Kidney Disease
• Chronic Obstructive Pulmonary Disease
• Heart Failure
• Infection

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Infection, Heart Failure | Status: WITHDRAWN